Free Trial

Beigene (ONC) Stock Forecast & Price Target

Beigene logo
$252.79 +2.95 (+1.18%)
As of 01:38 PM Eastern

Beigene - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
3

Based on 3 Wall Street analysts who have issued ratings for Beigene in the last 12 months, the stock has a consensus rating of "Buy." Out of the 3 analysts, 3 have given a buy rating for ONC.

Consensus Price Target

$327.00
29.36% Upside
According to the 3 analysts' twelve-month price targets for Beigene, the average price target is $327.00. The highest price target for ONC is $348.00, while the lowest price target for ONC is $313.00. The average price target represents a forecasted upside of 29.36% from the current price of $252.79.
Get the Latest News and Ratings for ONC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Beigene and its competitors.

Sign Up

ONC Analyst Ratings Over Time

TypeCurrent Forecast
3/13/24 to 3/13/25
1 Month Ago
2/12/24 to 2/11/25
3 Months Ago
12/14/23 to 12/13/24
1 Year Ago
3/14/23 to 3/13/24
Strong Buy
0 Strong Buy rating(s)
N/A N/A N/A
Buy
3 Buy rating(s)
N/A N/A N/A
Hold
0 Hold rating(s)
N/A N/A N/A
Sell
0 Sell rating(s)
N/A N/A N/A
Consensus Price Target$327.00N/AN/AN/A
Forecasted Upside29.36% UpsideN/AN/AN/A
Consensus Rating
Buy
N/AN/AN/A
Remove Ads

ONC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ONC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Beigene Stock vs. The Competition

TypeBeigeneMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.82
2.53
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside30.88% Upside24,762.71% Upside20.71% Upside
News Sentiment Rating
Neutral News

See Recent ONC News
Positive News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/3/2025Bank of America
3 of 5 stars
 UpgradeNeutral ➝ Buy$207.00 ➝ $320.00+17.73%
2/28/2025Guggenheim
2 of 5 stars
 Reiterated RatingBuy ➝ Buy
2/28/2025JMP Securities
2 of 5 stars
 Set Target$348.00+45.91%
2/28/2025Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Tony Ren
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$259.00 ➝ $313.00+16.12%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 01:58 PM ET.


ONC Forecast - Frequently Asked Questions

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Beigene is $327.00, with a high forecast of $348.00 and a low forecast of $313.00.

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Beigene in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ONC shares.

According to analysts, Beigene's stock has a predicted upside of 29.36% based on their 12-month stock forecasts.

Over the previous 90 days, Beigene's stock had 1 upgrade by analysts.

Beigene has been rated by research analysts at Bank of America, Guggenheim, JMP Securities, and Macquarie in the past 90 days.

Analysts like Beigene more than other "medical" companies. The consensus rating for Beigene is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ONC compares to other companies.


This page (NASDAQ:ONC) was last updated on 3/13/2025 by MarketBeat.com Staff
From Our Partners